ISLET AUTOANTIBODY MARKERS IN IDDM - RISK ASSESSMENT STRATEGIES YIELDING HIGH-SENSITIVITY

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • E BONIFACIO - , Chair of Preclinical stem cell therapy and diabetes (Author)
  • S GENOVESE - (Author)
  • S BRAGHI - (Author)
  • E BAZZIGALUPPI - (Author)
  • V LAMPASONA - (Author)
  • PJ BINGLEY - (Author)
  • L ROGGE - (Author)
  • MR PASTORE - (Author)
  • E BOGNETTI - (Author)
  • GF BOTTAZZO - (Author)
  • EAM GALE - (Author)
  • E BOSI - (Author)

Details

Original languageEnglish
Pages (from-to)816-822
JournalDiabetologia
Volume38
Issue number7
Publication statusPublished - Jul 1995
Peer-reviewedYes

External IDs

Scopus 0029040544
ORCID /0000-0002-8704-4713/work/141544304

Keywords

Research priority areas of TU Dresden

Sustainable Development Goals

ASJC Scopus subject areas

Keywords

  • ISLET CELL ANTIBODIES, GLUTAMIC ACID DECARBOXYLASE(65) ANTIBODIES, ISLET AUTOANTIGENS, INSULIN-DEPENDENT DIABETES MELLITUS PREDICTION, CARBOXYPEPTIDASE-H, ICA69